Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials
{{output}}
Type 1 diabetes (T1D) results in lifelong insulin therapy, but most people with T1D do not achieve glycemic targets using insulin alone. Adjunctive therapies such as once-weekly glucagon-like peptide-1 receptor agonists (GLP-1 RA) are approved for type 2 diabe... ...
